| Primary |
| Onychomycosis |
47.6% |
| Product Used For Unknown Indication |
17.0% |
| Fungal Infection |
8.4% |
| Tinea Pedis |
4.8% |
| Nail Infection |
4.3% |
| Fungal Skin Infection |
1.9% |
| Hypertension |
1.9% |
| Drug Use For Unknown Indication |
1.8% |
| Hypothyroidism |
1.7% |
| Contraception |
1.5% |
| Dementia Alzheimer's Type |
1.3% |
| Dermatophytosis |
1.1% |
| Back Pain |
0.9% |
| Depression |
0.9% |
| Nail Tinea |
0.9% |
| Tinea Cruris |
0.9% |
| Antifungal Treatment |
0.8% |
| Tinea Infection |
0.8% |
| Rash |
0.7% |
| Trichophytosis |
0.7% |
|
| Dysgeusia |
8.6% |
| Suicidal Ideation |
6.6% |
| Depression |
6.2% |
| Rash |
6.2% |
| Ageusia |
5.4% |
| Cutaneous Lupus Erythematosus |
5.4% |
| Hearing Impaired |
5.4% |
| Drug Interaction |
5.1% |
| Hepatitis |
5.1% |
| Visual Impairment |
5.1% |
| Deafness |
4.7% |
| Weight Decreased |
4.7% |
| Pancreatitis |
4.3% |
| Panic Attack |
4.3% |
| Paraesthesia |
4.3% |
| Skin Exfoliation |
4.3% |
| Urticaria |
3.9% |
| Cholestasis |
3.5% |
| Metrorrhagia |
3.5% |
| Rhabdomyolysis |
3.5% |
|
| Secondary |
| Onychomycosis |
15.9% |
| Fungal Infection |
13.6% |
| Drug Use For Unknown Indication |
9.3% |
| Aortic Valve Replacement |
7.5% |
| Product Used For Unknown Indication |
7.5% |
| Systemic Mycosis |
6.1% |
| Lyme Disease |
5.6% |
| Trichophytosis |
5.6% |
| Hypertension |
4.2% |
| Nail Infection |
3.3% |
| Nail Tinea |
2.8% |
| Tuberculosis |
2.8% |
| Blood Cholesterol Increased |
2.3% |
| Blood Pressure Increased |
2.3% |
| Depression |
2.3% |
| Schizoaffective Disorder Bipolar Type |
2.3% |
| Immunosuppressant Drug Therapy |
1.9% |
| Reflux Oesophagitis |
1.9% |
| Analgesia |
1.4% |
| Diabetes Mellitus |
1.4% |
|
| Drug Interaction |
10.9% |
| Septic Shock |
9.1% |
| Cerebrovascular Accident |
7.3% |
| Cutaneous Lupus Erythematosus |
7.3% |
| Depression |
7.3% |
| Tremor |
7.3% |
| Bone Marrow Necrosis |
5.5% |
| Rhabdomyolysis |
5.5% |
| Weight Increased |
5.5% |
| Extrapyramidal Disorder |
3.6% |
| Hepatitis Acute |
3.6% |
| Hyperhidrosis |
3.6% |
| Neutrophil Count Decreased |
3.6% |
| Onychomycosis |
3.6% |
| Polyneuropathy |
3.6% |
| Rash |
3.6% |
| Urinary Tract Infection |
3.6% |
| Abdominal Discomfort |
1.8% |
| Abortion Spontaneous |
1.8% |
| Acute Generalised Exanthematous Pustulosis |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.6% |
| Rheumatoid Arthritis |
12.3% |
| Drug Use For Unknown Indication |
12.1% |
| Hiv Infection |
5.9% |
| Prophylaxis |
5.0% |
| Hypertension |
4.9% |
| Onychomycosis |
4.5% |
| Pain |
4.5% |
| Diabetes Mellitus |
4.0% |
| Insomnia |
3.9% |
| Osteoporosis |
3.3% |
| Gastritis Prophylaxis |
3.0% |
| Breast Cancer |
2.8% |
| Depression |
2.5% |
| Mycobacterium Avium Complex Infection |
2.5% |
| Rash |
2.0% |
| Abdominal Pain |
1.9% |
| Arthralgia |
1.8% |
| Vitamin Supplementation |
1.8% |
| Crohn's Disease |
1.7% |
|
| Rash |
8.1% |
| Neoplasm Malignant |
7.1% |
| Pulmonary Embolism |
7.1% |
| Pyelonephritis Acute |
7.1% |
| Renal Tubular Necrosis |
7.1% |
| White Blood Cell Count Increased |
7.1% |
| Pain |
6.1% |
| Arthralgia |
5.1% |
| Toxic Epidermal Necrolysis |
5.1% |
| Acute Myeloid Leukaemia |
4.0% |
| Aspartate Aminotransferase Increased |
4.0% |
| Death |
4.0% |
| Drug Ineffective |
4.0% |
| Headache |
4.0% |
| Visual Acuity Reduced |
4.0% |
| Vomiting |
4.0% |
| Femur Fracture |
3.0% |
| Granulocytopenia |
3.0% |
| Liver Injury |
3.0% |
| Myalgia |
3.0% |
|
| Interacting |
| Onychomycosis |
43.5% |
| Hypertension |
8.7% |
| Mental Disorder |
8.7% |
| Product Used For Unknown Indication |
8.7% |
| Tinea Infection |
8.7% |
| Fungal Infection |
4.3% |
| Hypothyroidism |
4.3% |
| Intraocular Pressure Increased |
4.3% |
| Nail Infection |
4.3% |
| Schizoaffective Disorder |
4.3% |
|
| Drug Interaction |
33.3% |
| Persecutory Delusion |
13.3% |
| Aspartate Aminotransferase Increased |
6.7% |
| Delusion |
6.7% |
| Hallucination |
6.7% |
| Hypoglycaemia |
6.7% |
| Ocular Hyperaemia |
6.7% |
| Off Label Use |
6.7% |
| Onychomycosis |
6.7% |
| Tachycardia |
6.7% |
|
